SSRI and Buprenorphine

• Status: Completed
• Trial end date: 2009-09-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is designed to test whether treatment of depressive symptoms using escitalopram improves adherence to Buprenorphine and reduces symptoms of depression for individuals receiving Buprenorphine through their medical provider.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Butler Hospital
• Treatments: Buprenorphine; Citalopram; Dexetimide

Criteria

Inclusion Criteria:

• opiate dependence

• Ham-D > 14

Exclusion Criteria:

• no psychiatric contraindications to using escitalopram

• no medical contraindications to using escitalopram

• methadone dose < 30

• no current SSRI use